NCT00399048: An Effectiveness, Safety and Quality of Life Measures With Hydromorphone HCL, Dilaudid CR (Controlled Release) |
|
|
| Completed | 3 | 140 | US | OROS hydromorphone HCL ; OxyContin | Alza Corporation, DE, USA | Osteoarthritis, Knee, Osteoarthritis, Hip | | 05/01 | | |
